Invention Grant
![Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections](/docs/US/2019-08-13/US10377761B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
-
Application No.: US16045371Application Date: 2018-07-25
-
Publication No.: US10377761B2Publication Date: 2019-08-13
- Inventor: Michael O'Neil Hanrahan Clarke , Edward Doerffler , Richard L. Mackman , Dustin Siegel
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agent Reena Bajpai
- Main IPC: C07H7/06
- IPC: C07H7/06 ; C07D487/04 ; C07D405/14 ; C07D405/04 ; C07F9/6561
![Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections](/abs-image/US/2019/08/13/US10377761B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are formulations, methods and substituted tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds of Formula (I) for treating Pneumovirinae virus infections, including respiratory syncytial virus infections, as well as methods and intermediates for synthesis of tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds.
Public/Granted literature
- US20190055253A1 PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Public/Granted day:2019-02-21
Information query
